Laddar…
Durvalumab After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: Inferior Outcomes and Lack of Health Equity in Hispanic Patients Treated With PACIFIC Protocol (LA1-CLICaP)
OBJECTIVES: To compare the rate disparity between outcomes (overall survival (OS), progression-free survival (PFS), and safety) of concurrent chemoradiation (cCRT) followed by durvalumab in two patient cohorts with locally advanced (LA) stage III non-small cell lung cancer (NSCLC), one non-Hispanic...
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Online Artikel Text |
Språk: | English |
Publicerad: |
Frontiers Media S.A.
2022
|
Ämnen: | |
Länkar: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321635/ https://www.ncbi.nlm.nih.gov/pubmed/35903685 http://dx.doi.org/10.3389/fonc.2022.904800 |